COMPARATIVE ANALYSIS OF GLOBAL PEADIATRIC DRUG DEVELOPMENT REGULATIONS: EMERGING TRENDS AND FUTURE HARMONIZATION
Chaya M.*, Sanjana P. S., Sai Nikhil V., Nithya T., Namratha V., Yukthashree R. I.
ABSTRACT
The study and development of paediatric medications focus on ensuring the safety, effectiveness, quality, and appropriate dosages of medications. The materials used to regulate the creation of drugs are crucial, and the methods followed for better harmonisation. The development of paediatric drugs is governed by the US Food and Drug Administration, the European Medicines Agency, and the central drug standard control organisation. These organisations adopt ICH recommendations such as ICH E11/E11(R1) and ICH S11 as part of their framework. Comparative analysis of paediatric drugs at the global level for better drug action depends on metabolic rate and regulatory protocols in both children and adolescents.Pharmaceutical innovation for children; comparative evaluation; paediatric formulation; Paediatric pharmacovigilance.
Keywords: Pharmaceutical innovation for children; comparative evaluation; paediatric formulation; Paediatric pharmacovigilance.
[Full Text Article]
[Download Certificate]